Skip to main navigation

BioAtla, Inc logo

preloader
BioAtla, Inc logo
  • Overview
  • News & Events
    • News Releases
    • Events and Presentations
  • Governance
    • Governance Overview
    • Board of Directors
    • Management
    • Committee Composition
  • Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  • Stock
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

SEC Filing Details

Document Details

Form
SC 13G/A
Filing Date
Feb 14, 2023
Document Date
Feb 14, 2023
Form Description
An amendment to the SC 13G filing
Filing Group
Other
Company
BioAtla, Inc
Issuer
BIOATLA, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
logo-footer

BioAtla® is a leading San Diego-based biopharmaceutical company developing safer and more effective drugs for cancer. Its Conditionally Active Biologics™ (CAB) platform exploits the unique microenvironment of diseased tissue to more effectively target cancer.

BIOATLA®

  • Technology
  • CAB Portfolio
  • Appendix

COMPANY

  • About
  • Team
  • Careers
  • News

LEGAL

  • Privacy Policy
  • Site Map
  • Expanded Access

GET IN TOUCH

  • Contact
  • Corporate Headquarters +1 858-558-0708

FOLLOW US

  • LinkedIn
  • Copyright © 2023 BioAtla®, Inc. All rights reserved